Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl V Hanson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
AIDS (London, England)|July 16, 2014
Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogenStephanie A Planque, Yukie Mitsuda, Vida Chitsazzadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2012
Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccineStephanie A Planque, Yukie Mitsuda, Yasuhiro Nishiyama, et al.
AIDS (London, England)|February 27, 2010
Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infectionStephanie Planque, Maria Salas, Yukie Mitsuda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2019
Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV EnvelopeKrystal Teasley Hamorsky, J Calvin Kouokam, Matthew W Dent, et al.
International Journal of Pharmaceutics|May 29, 2012
A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIVStephen E Gerrard, Mary Lynn Baniecki, David C Sokal, et al.
Plos One|June 19, 2010
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityNobuyuki Matoba, Adam S Husk, Brian W Barnett, et al.
Vaccine|November 22, 2002
Synthetic AIDS vaccine by targeting HIV receptorChang Yi Wang, Ming Shen, Gary Tam, et al.
Plos One|July 1, 2021
Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infectionKelly A Curtis, Donna L Rudolph, Yi Pan, et al.
Nature Biomedical Engineering|October 30, 2020
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substratesTiancheng Liu, Jessica Hsiung, Su Zhao, et al.
The New England Journal of Medicine|April 18, 2019
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment InterruptionChang-Yi Wang, Wing-Wai Wong, Hung-Chin Tsai, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|July 16, 2014
Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogenStephanie A Planque, Yukie Mitsuda, Vida Chitsazzadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2012
Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccineStephanie A Planque, Yukie Mitsuda, Yasuhiro Nishiyama, et al.
AIDS (London, England)|February 27, 2010
Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infectionStephanie Planque, Maria Salas, Yukie Mitsuda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2019
Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV EnvelopeKrystal Teasley Hamorsky, J Calvin Kouokam, Matthew W Dent, et al.
International Journal of Pharmaceutics|May 29, 2012
A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIVStephen E Gerrard, Mary Lynn Baniecki, David C Sokal, et al.
Plos One|June 19, 2010
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityNobuyuki Matoba, Adam S Husk, Brian W Barnett, et al.
Vaccine|November 22, 2002
Synthetic AIDS vaccine by targeting HIV receptorChang Yi Wang, Ming Shen, Gary Tam, et al.
Plos One|July 1, 2021
Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infectionKelly A Curtis, Donna L Rudolph, Yi Pan, et al.
Nature Biomedical Engineering|October 30, 2020
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substratesTiancheng Liu, Jessica Hsiung, Su Zhao, et al.
The New England Journal of Medicine|April 18, 2019
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment InterruptionChang-Yi Wang, Wing-Wai Wong, Hung-Chin Tsai, et al.
Pageof 4